Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial-Reference-Cited by-同舟云学术

Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial

Published:2011-11 Issue:9803 Volume:378 Page:1627-1634
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Göpel Wolfgang,Kribs Angela,Ziegler Andreas,Laux Reinhard,Hoehn Thomas,Wieg Christian,Siegel Jens,Avenarius Stefan,von der Wense Axel,Vochem Matthias,Groneck Peter,Weller Ursula,Möller Jens,Härtel Christoph,Haller Sebastian,Roth Bernhard,Herting Egbert

Publisher

Elsevier BV

Subject

General Medicine

Reference31 articles.

1. Non-invasive ventilation in acute respiratory failure;Nava;Lancet,2009

2. Nasal CPAP or intubation at birth for very preterm infants;Morley;N Engl J Med,2008

3. Early CPAP versus surfactant in extremely preterm infants;N Engl J Med,2010

4. Animal derived surfactant extract for treatment of respiratory distress syndrome;Seger;Cochrane Database Syst Rev,2009

5. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial;Rojas;Pediatrics,2009

Cited by 399 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Less Invasive Surfactant Administration for Preterm Infants – State of the Art;Neonatology;2024-09-03

2. Feasibility and safety of surfactant administration via laryngeal mask airway as first-line therapy for a select newborn population: results of a standardized clinical protocol;Journal of Perinatology;2024-08-30

3. Randomised cross-over study of thin catheters used for less invasive surfactant delivery in a newborn manikin;Archives of Disease in Childhood - Fetal and Neonatal Edition;2024-07-11

4. Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind, placebo-controlled, investigator-initiated phase 3 trial;The Lancet Respiratory Medicine;2024-07

5. Surfactant administration methods for premature newborns: LISA vs. INSURE comparative analysis;Journal of Neonatal-Perinatal Medicine;2024-05-16